Here's Why Investors Should Retain Integra (IART) Stock Now

Integra LifeSciences Holdings Corporation (IART) is well-poised to grow in the coming quarters, given the healthy demand for its industry-leading products within Codman Specialty Surgical (“CSS”). The company’s strong overseas performance is encouraging, while strategic initiatives undertaken will help reach a wider customer base. In addition, efforts to optimize the portfolio with new acquisitions and product developments buoy optimism. Meanwhile, headwinds from currency fluctuations and escalated expenses ...